Comparison of fluticasone propionate and budesonide on COPD macrophage and neutrophil function
File(s)
Author(s)
Belchamber, KBR
Thomas, Catherine
Dunne, Amy
Barnes, peter
Donnelly, louise
Type
Journal Article
Abstract
Background: Inhaled corticosteroid (ICS) use is associated with increased rates of pneumonia in COPD patients. The underlying mechanism is unknown although recent data suggest that pneumonia is more frequent in patients treated with fluticasone propionate (FP) than budesonide. Macrophages and neutrophils from COPD patients are deficient in clearing bacteria and this might explain increased bacterial colonisation in COPD. ICS may further suppress this response; therefore, we examined the effect of FP and budesonide on phagocytosis of common respiratory pathogens by monocyte-derived macrophages (MDM) and neutrophils.
Methods: MDM from COPD patients (n=20-24) were pre-incubated with FP or budesonide for 1 or 18 h after which phagocytosis of fluorescently labelled inert beads or heat-killed Haemophilus influenzae or Streptococcus pneumoniae were measured fluorimetrically after 1 or 4 h. Additionally, the following was measured: CXCL-8, IL-6 and TNFα concentrations in supernatants by ELISA, MDM scavenger receptor expression by flow cytometry, and the MDM ability to kill bacteria. Neutrophils from COPD patients (n=8) were pre-incubated with corticosteroids for 1 h, and phagocytosis of bacteria was measured by flow cytometry.
Results: After 1 h pre-incubation, neither corticosteroid altered MDM phagocytosis of beads or H. influenzae; however, budesonide (10-7M) increased phagocytosis of S. pneumoniae by 23% (P<0.05). After 18 h pre-incubation, neither corticosteroid altered MDM phagocytosis of any prey, although phagocytosis of H. influenzae by budesonide was significantly greater compared to FP at 10-6 and 10-5M (P<0.05). The 1 h pre-incubation with either corticosteroid inhibited bacteria-induced CXCL-8 release (at 10-7 and 10-5M, P<0.05); however, this effect was lost at 18 h pre-incubation. There was no change in receptor expression, bacterial killing or neutrophil phagocytosis by either corticosteroid.
Conclusions: These data suggest that dissolved FP and budesonide do not have an overall effect on MDM or neutrophil phagocytosis of bacteria.
Methods: MDM from COPD patients (n=20-24) were pre-incubated with FP or budesonide for 1 or 18 h after which phagocytosis of fluorescently labelled inert beads or heat-killed Haemophilus influenzae or Streptococcus pneumoniae were measured fluorimetrically after 1 or 4 h. Additionally, the following was measured: CXCL-8, IL-6 and TNFα concentrations in supernatants by ELISA, MDM scavenger receptor expression by flow cytometry, and the MDM ability to kill bacteria. Neutrophils from COPD patients (n=8) were pre-incubated with corticosteroids for 1 h, and phagocytosis of bacteria was measured by flow cytometry.
Results: After 1 h pre-incubation, neither corticosteroid altered MDM phagocytosis of beads or H. influenzae; however, budesonide (10-7M) increased phagocytosis of S. pneumoniae by 23% (P<0.05). After 18 h pre-incubation, neither corticosteroid altered MDM phagocytosis of any prey, although phagocytosis of H. influenzae by budesonide was significantly greater compared to FP at 10-6 and 10-5M (P<0.05). The 1 h pre-incubation with either corticosteroid inhibited bacteria-induced CXCL-8 release (at 10-7 and 10-5M, P<0.05); however, this effect was lost at 18 h pre-incubation. There was no change in receptor expression, bacterial killing or neutrophil phagocytosis by either corticosteroid.
Conclusions: These data suggest that dissolved FP and budesonide do not have an overall effect on MDM or neutrophil phagocytosis of bacteria.
Date Issued
2018-09-17
Date Acceptance
2018-05-16
Citation
International Journal of COPD, 2018, 2018 (13), pp.2883-2897
ISSN
1176-9106
Publisher
Dove Medical Press
Start Page
2883
End Page
2897
Journal / Book Title
International Journal of COPD
Volume
2018
Issue
13
Copyright Statement
© 2018 Belchamber et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)
and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you
hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission
for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php)
Sponsor
AstraZeneca AB
AstraZeneca AB
Identifier
https://www.dovepress.com/comparison-of-fluticasone-propionate-and-budesonide-on-copd-macrophage-peer-reviewed-article-COPD
Grant Number
PO No. 8400064069
n/a
Subjects
Science & Technology
Life Sciences & Biomedicine
Respiratory System
COPD
macrophage
neutrophil
fluticasone propionate
hudesonide
INHALED CORTICOSTEROIDS
PROPIONATE/SALMETEROL 250/50
ALVEOLAR MACROPHAGES
PHAGOCYTOSIS
PNEUMONIA
RISK
CELLS
EXACERBATIONS
CHEMOTAXIS
EXPRESSION
COPD
budesonide
fluticasone propionate
macrophage
neutrophil
Aged
Budesonide
Cells, Cultured
Cohort Studies
Enzyme-Linked Immunosorbent Assay
Female
Fluticasone
Haemophilus influenzae
Humans
Macrophages
Male
Neutrophils
Phagocytosis
Pulmonary Disease, Chronic Obstructive
Sensitivity and Specificity
Streptococcus pneumoniae
United Kingdom
Neutrophils
Cells, Cultured
Macrophages
Humans
Haemophilus influenzae
Streptococcus pneumoniae
Pulmonary Disease, Chronic Obstructive
Budesonide
Enzyme-Linked Immunosorbent Assay
Sensitivity and Specificity
Cohort Studies
Phagocytosis
Aged
Female
Male
Fluticasone
United Kingdom
1102 Cardiorespiratory Medicine and Haematology
Respiratory System
Publication Status
Published
Date Publish Online
2018-09-17